Peptides play a key role in the growing segment of biopharmaceuticals. Peptidebased drug targets are being identified at an increasingly rapid pace and a variety of new peptide drugs are being developed as novel therapies for cancer, pain treatment,
viral infections, diabetes and a host of endocrine and neurological disorders.